Location History:
- Chiba, JP (1995)
- Mobara, JP (1993 - 1998)
- Chiba-ken, JP (1998)
Company Filing History:
3 out of 1,788 
3 out of 1,379 
Years Active: 1993-1998
Title: Daiji Iwata: Innovator in Anticancer and Antiviral Agents
Introduction
Daiji Iwata is a prominent inventor based in Mobara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as anticancer, antiviral, and antimicrobial agents. With a total of 6 patents to his name, Iwata's work has had a notable impact on medical research and drug development.
Latest Patents
Among his latest patents are the benzimidazole derivatives and phenylbenzimidazole derivatives. These compounds are described as effective agents for acting on DNA, showcasing their potential in treating various diseases. The active ingredients in these formulations are designed to combat cancer and viral infections, highlighting Iwata's commitment to advancing healthcare solutions.
Career Highlights
Iwata has worked with notable companies such as Mitsui Chemicals, Inc. and Mitsui Toatsu Chemicals Incorporated. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Iwata has collaborated with esteemed colleagues, including Akio Matsunaga and Hiroshi Kohno. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.
Conclusion
Daiji Iwata's contributions to the pharmaceutical industry through his innovative patents and collaborations underscore his role as a key figure in the fight against cancer and viral diseases. His work continues to inspire advancements in medical research and drug development.